◀ Back to MAPK3
BTRC — MAPK3
Text-mined interactions from Literome
Bondzi et al., Cell Growth Differ 2000
(Carcinoma, Small Cell...) :
In the present study, we have demonstrated that PP1, a pharmacological inhibitor of Src kinases, blocked
SCF mediated
activation of
mitogen activated protein ( MAP ) kinase , but it also inhibited Kit activation
Krystal et al., Clin Cancer Res 2000
(Carcinoma, Small Cell...) :
STI571 efficiently blocked
SCF mediated activation of
mitogen activated protein kinase and Akt, but did not affect insulin-like growth factor-1 or serum mediated mitogen activated protein kinase or Akt activation
Jacobs-Helber et al., J Biol Chem 1997
(Leukemia, Erythroblastic, Acute) :
SCF induced proliferation, SHC phosphorylation, and activation of
ERK-1 but did not activate the JAK/STAT pathway ... SCF stimulated SHC phosphorylation and ERK-1 activation independent of the EPOR in cells where the EPOR was down-regulated ; the presence of the EPOR appeared to facilitate
SCF activation of SHC and
ERK-1